# Haibon fenghua VC

> Haibon fenghua VC is a VC fund in Hangzhou backing Medical, Manufacturing and Hospital. See 6 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Hangzhou, China
- Total investments: 6
- Last investment: Dec 2025
- Lead investor: 50%
- Last updated: Aug 2026
- Website: http://www.fenghuavc.cn

Haibon fenghua VC is a VC fund in Hangzhou focused on Medical and Manufacturing. Haibon Fenghua is an investment business that specializes on early and mid-stage equity investments in biomedicine, artificial intelligence, big data, and high-end manufacturing.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 2 | 33% |
| Manufacturing | 2 | 33% |
| Hospital | 1 | 17% |
| Wellness | 1 | 17% |
| Aerospace | 1 | 17% |

10 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 3 | 50% |
| Series A | 2 | 33% |
| Series B | 1 | 17% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Dream Chasing Sky | Dream Chasing Sky specializes on electric vertical take-off and landing aircraft research and development. | $28.3M | Series A | Dec 08, 2025 |  |
| Dream Chasing Sky | Dream Chasing Sky specializes on electric vertical take-off and landing aircraft research and development. | $13.9M | Seed | Aug 21, 2025 |  |
| Lingmo Medical | Lingmo Medical is a company that provides department-level flexible endoscopic solutions.It is advancing the development of flexible endoscopy and providing higher-quality endoscopic solutions for clinicians and patients, allowing more risk categories to benefit from it. Benefit from endoscopic diagnosis and treatment. |  | Series A | Apr 07, 2025 |  |
| Lingmo Medical | Lingmo Medical is a company that provides department-level flexible endoscopic solutions.It is advancing the development of flexible endoscopy and providing higher-quality endoscopic solutions for clinicians and patients, allowing more risk categories to benefit from it. Benefit from endoscopic diagnosis and treatment. |  | Seed | May 11, 2024 |  |
| Xingrong Technology | Xingrong Technology is an electronic component company that offers services to consumers including fabrication of electronic components. |  | Seed | Mar 14, 2024 |  |
| Linstant | Linsheng Materials is a medical device accessories supplier that specializes in offering "one-to-one" tailored solutions for minimally invasive medical device companies and medical device accessories manufacturing services. | $14.1M | Series B | Jan 08, 2024 |  |

6 of 6 investments shown.

## Co-investors
- [Peakvest](https://shizune.co/investors/profile/peakvest) — VC Fund, 2 deals together
- [China Civil Aviation Private Equity Fund](https://shizune.co/investors/profile/china-civil-aviation-private-equity-fund) — VC Fund, 1 deal together
- [Commerce Fund](https://shizune.co/investors/profile/commerce-fund) — VC Fund, 1 deal together
- [CS Capital](https://shizune.co/investors/profile/cs-capital) — VC Fund, 1 deal together
- [Deqing Capital](https://shizune.co/investors/profile/deqing-capital) — VC Fund, 1 deal together
- [Haiyuan Capital](https://shizune.co/investors/profile/goldport-capital) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Gaingels](https://shizune.co/investors/profile/gaing) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [IDG Capital](https://shizune.co/investors/profile/idg-capital-partners) — VC Fund
- [Qiming Venture Partners](https://shizune.co/investors/profile/qiming-venture-partners) — VC Fund
- [HSG](https://shizune.co/investors/profile/sequoia-capital-china) — VC Fund

## Featured in investor lists
- [Wellness Investors in China](https://shizune.co/investors/wellness-investors-china)
- [Wellness VC Funds in China](https://shizune.co/investors/wellness-vc-funds-china)

## FAQ

### What does Haibon fenghua VC invest in?

Haibon fenghua VC invests primarily in Medical, Manufacturing and Hospital startups, most often at Seed and Series A stage. Most of the 6 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Haibon fenghua VC last invest?

The most recent investment recorded for Haibon fenghua VC closed in Dec 2025. Shizune tracks 6 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co